Cancer Home > Cladrobine
Were you looking for information about Cladribine? Cladrobine is a common misspelling of cladribine.
Cladribine (Leustatin®) is a medicine licensed for the treatment of hairy cell leukemia in adults. It is available by prescription only and comes as an injection that is given slowly into a vein (intravenously, or by IV) continuously for seven days.
Before you begin treatment with this chemotherapy drug, your healthcare provider will want to know if you have kidney disease, are pregnant or breastfeeding, or have any allergies. Potential side effects of cladribine include fever, fatigue, and infections.
(Click Cladribine for a closer look at this chemotherapy drug, including how it works, who makes it, and safety precautions. You can also click any of the links in the box to the right for specific information.)